Home » Topics » BioWorld Science

BioWorld Science
RSS

Aldose reductase inhibitors from Terumo

Aug. 30, 1996

Sankyo reports novel hypoglycemic agents

Aug. 30, 1996

Positive efficacy/safety profile for maximal-dose sulfonylurea therapy reported

Aug. 30, 1996

Expanded H-BIG clinical development program announced

Aug. 30, 1996

Yamanouchi reveals 5HT3 agonist

Aug. 30, 1996

Provir effective in patients with travelers' diarrhea

Aug. 30, 1996

FDA approves Helidac for marketing

Aug. 30, 1996

OP-1 role in kidney formation investigated

Aug. 30, 1996

Taisho discloses agents for urinary incontinence

Aug. 30, 1996

Reliance approved for marketing in U.S.

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 11, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Flow Neuro wins FDA nod for at-home device for depression
BioWorld MedTech
Flow Neuroscience AB received U.S. FDA 510(k) approval for its Flow at-home brain-stimulation device to treat major depressive disorder. The wearable headset uses...